Tolia Maria
September 16, 2025 2025-09-16 14:56Tolia Maria
Tolia Maria
Associate Professor of Radiotherapy
Medical School, University of Crete, P.C. 70013 Heraklion, Crete
I was born in Athens in 1974 and graduated from the Medical School of the University of Insubria in Varese, Lombardia, Italy (Università di Medicina e Chirurgia d’Insubria, Varese, Lombardia, Italia), in 2002 (Grade: “Very Good”). I specialized in Radiation Oncology at the “Alexandra” Hospital (2006-2009). I completed my doctoral thesis entitled: “Radiobiological study of conventional and accelerated radiotherapy regimen in patients suffering from squamous cancer of the head and neck” at the 2nd Radiology Laboratory of the Attikon University Hospital, Medical School of the University of Athens (Grade: Excellent). I worked as an Assistant Professor at the Department of Medicine, School of Health Sciences, University of Thessaly – Director of the Radiotherapy Laboratory at the University General Hospital of Larissa. I work as an Associate Professor at the Medical School of the University of Crete – Director of the Radiation Oncology Laboratory at the University General Hospital of Heraklion, Crete.
25/01/2006 – 31/05/2009 Specialization in Radiation Oncology at Alexandra Hospital.
1/2/09-30/4/09 Specialization in Radiation Oncology at the San Rafaelle Hospital, Milan, Italy (Head: Ms. Di Muzio Nadia Gizella, Director Professor of Radiotherapy, Medical School of the University of Milano).
Training in the techniques of Stereotactic Radiosurgery/Radiotherapy (GammaKnife), Image Guided Radiotherapy – IGRT (Tomotherapy), Intensity Modulated Radiotherapy – IMRT, Brachytherapy.
12/5/09-15/7/09 Specialization in Radiation Oncology at the Instituto Europeo Di Oncologia Hospital/Milan, Italy (Head: Mr. Roberto Orecchia, Professor of Radiotherapy, Medical School of the University of Milano).
Training in Stereotactic Radiosurgery/Stereotactic Radiotherapy (SRS/SBRT), Image Guided Radiotherapy (IGRT), Intensity Modulated Radiotherapy (IMRT), Intraoperative RT (IORT), Partial Breast Irradiation (PBI), intra-tissue, intraluminal, intracavitary brachytherapy and radioactive seed implantation.
1/9/2015-23/9/2015 Postgraduate Training in Radiation Oncology The University of Texas MD Anderson Cancer Center, Houston, Texas USA.
Breast radiotherapy training (Associate Professor of Radiation Oncology The University of Texas MD Anderson Cancer Center, Houston, Texas, Mr. Eric Strom) Intensity-modulated radiotherapy (IMRT), Volumetric modulated arc therapy (VMAT), Endoscopic Brachytherapy, Protons, Respiratory Gating, Stereotactic radiosurgery/Stereotactic Radiotherapy (SRS/SBRT).
Head and neck radiotherapy training (Associate Professor of Radiation Oncology Mr. David Rosenthal, The University of Texas MD Anderson Cancer Center, Houston, Texas,) Intensity-modulated radiotherapy (IMRT), Intensity-modulated Proton Therapy (IMPT), Gating, Volumetric modulated arc therapy (VMAT), Stereotactic radiosurgery/Stereotactic Radiotherapy (SRS/SBRT).
13/9/2022-14/10/2022 Postgraduate Training in Radiation Oncology at Mater Art Hospital, Olbia, Sardinia, Italy (Head of the training: Mr. Gian Carlo Mattiucci, Professor of Radiation Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC di Radioterapia, Dipartimento di Scienze Radiologiche, Radioterapiche ed Hematologiche, Roma, Italia), in the following techniques: IMRT, VMAT, Stereotactic Radiosurgery/Stereotactic Radiotherapy (SRS/SBRT), Adaptive Radiotherapy, MRI Linac Radiotherapy.
09/09/2024-16/09/2024 Postgraduate training in Radiation Oncology, in Stereotactic Radiosurgery/Radiotherapy techniques with Cyberknife at the University Hospital San Rafaelle, Milan, Italy (Responsible Ms. Di Muzio Nadia Gizella, Director Professor of Radiotherapy, Medical School of the University of Milano).
Breast cancer
Gynecological cancer
ISI Publications
1.Hypofractionated radiotherapy in non small cell lung cancer: a review of the current literature. Beli I, Koukourakis G, Platoni K, Tolia M, Kelekis N, Kouvaris J, Syrigos C, Mystakidou K, Varveris C, Kouloulias V. Rev Recent Clin Trials. 2010;5(2):103-111.
2. Clinical implementation of total skin electron beam (TSEB) therapy: a review of the relevant literature. Diamantopoulos S, Platoni K, Dilvoi M, Nazos I, Geropantas K, Maravelis G, Tolia M, Beli I, Efstathopoulos E, Pantelakos P, Panayiotakis G, Kouloulias V.Phys Med. 2011;27(2):62-68.
3. Grade III Dermatitis in a Patient Treated With Paclitaxel and Radiotherapy: Case Report and Review of the Literature. Zygogianni A, Gennatas K, Kouvaris J, Kantzou I, Antypas C, Tolia M, Kouloulias V. World J Oncol. 2011 Jun;2(3):143-146. doi: 10.4021/wjon314w. Epub 2011 Jun 8. PMID: 29147239; PMCID: PMC5649668.
4. Effect of Cetuximab and mutations of KRAS gene in colon cancer. Tsoukalas N, Tzovaras A, Tolia M, Papacostidi A,Kostakis I, Ardavanis A,Barbounis B. Archives of Hellenic Medicine. 2011; 28(9):1-6.
5. Assessment of contralateral mammary gland dose in the treatment of breast cancer using accelerated hypofractionated radiotherapy. Tolia M, Platoni K, Foteineas A, Kalogeridi MA, Zygogianni A, Tsoukalas N, Caimi M, Margari N, Dilvoi M, Pantelakos P, Kouvaris J, Kouloulias V. World J Radiol. 2011;3(9):233-240.
6. The potential role of radiation therapy in Bowen’s disease: a review of the current literature. Zygogianni AG, Kouvaris J, Tolia M, Kyrgias G, Beli I, Kantzou I, Soulimioti G, Kouloulias V. Rev Recent Clin Trials. 2012;7(1):42-46.
7. Colorectal cancer: Adverse effects of antineoplastic treatment. Review.Tsoukalas N, Papakostidi A, Tolia M. Archives of Hellenic Medicine.2012;29(3):1-6.
8.Coexistence of intracranial germ cell tumor and craniopharyngioma in an adolescent: case report and review of the literature. Tsoukalas N, Tolia M, Kostakis ID, Pistamaltzian N, Tryfonopoulos D, Lypas G, Koumakis G, Barbounis V, Goutas N, Efremidis A. Int J Clin Exp Med. 2013;6 (3):211-218.
9. Evaluation of Acute Toxicity and Symptoms Palliation in a Hypofractionated Weekly Schedule, for Elderly Patients with Muscular Invasive Bladder Cancer. Kouloulias V, Tolia M, Kolliarakis N, Siatelis A, Kelekis N. Int Braz J Urol. 2013;39(1):77-82.
10. Changes of acute-phase protein levels in the serum of lung cancer patients following radiotherapy. Tolia Μ, Kouloulias V, Pantelakos P, Syrigos K. Int J Clin Exp Med. 2013; 6(1): 50–56.
11. Dermatomyositis as an early manifestation and a significant clinical precursor of lung cancer: report of a rare case and review of the current literature.Tsoukalas N, Tolia Μ, Kostakis DI, Lypas G, Pistamaltzian N, Demiri S, Panopoulos C, Koumakis G, Barbounis V, Efremidis A. Int J Clin Exp Med. 2013; 6(2): 105–109.
12. Sucralfate gel as a radioprotector against radiation induced dermatitis in a hypofractionated schedule: a non-randomized study. Kouloulias V, Asimakopoulos C, Tolia M, Filippou G, Platoni K, Dilvoi M, Beli I, Georgakopoulos J, Kelekis N. Hippokratia. 2013;17(2):126-129.
13. Evaluation of Acute/Late Toxicity and local recurrence in an accelerated Hypofractionated 3D-Conformal External Beam Radiotherapy (3D-CRT) schedule, in Τ1-Τ2 glottic carcinoma. Kouloulias VE, Zygogianni A, Mosa E, Platoni K, Georgakopoulos J, Antypas C, Beli I, Tolia M, Maragoudakis P, Giotakis I, Papas Z, Psyrri A, Kelekis N, Kouvaris J. Radiology and Oncology 2013;47(2):185-191.
14. Complete remission of a recurrent mesenteric liposarcoma with rare histologic features after administration of trabectedin. Tsoukalas N, Tolia M, Lypas G, Panopoulos C, Barbounis V, Koumakis G, Efremidis A. Oncology Letters. 2014;7(1):47-49.
15. Review. The key role of Bisphosphonates in the Supportive Care of Cancer Patients. Tolia M, Zygogianni A, Kouvaris JR, Meristoudis C, Margari N, Karakitsos P, Kokakis I, Kardamakis D, Papadimitriou C, Mystakidou K, Tsoukalas N, Kyrgias G, Armonis B, Filippiadis D, Kelekis A, Kelekis N, Kouloulias V. Anticancer Research. 2014;34(1):23-37.
16. A Collecting Duct Carcinoma Producing Carcinoembryonic Antigen and Ca-125 in a 29-Year-Old Woman.Tsoukalas N, Kostakis I, Tolia M,Tryfonopoulos D, Lypas G, Panopoulos C, Barbounis V, Koumakis G, Efremidis A.International Urology and Nephrology. 2014.Doi: 10.1007/s11255-014-0660-y.
17. Risk Factors Pathological and Phenotypic Features of Male Breast Cancer in Greece. N. Tsoukalas, E Moirogiorgou, M Tolia, N Pistamaltzian,E Bournakis, K Papadimitriou, S Demiri,C Panopoulos, G Koumakis, A Efremidis. Anticancer Research. 2014;34(3):1291-1294.
18. Irradiation Toxicity and Inflammatory Bowel Diseases (IBD): Review. Tolia M, Zygogianni A, Kouvaris JR, Tsoukalas N, Kokakis I, Kyrgias G, Mystakidou K, Kouloulias V.
Rev Recent Clin Trials. 2014;9(1):31-36.
Θεματολογία: Αξιολόγηση της μετακτινικής τοξικότητας σε ογκολογικούς ασθενείς, πάσχοντες από φλεγμονώδεις νόσους του εντέρου.
Μεθοδολογία: Ανασκόπηση
19. Epithelial-Mesenchymal Transition in Non Small-cell Lung Cancer. Tsoukalas N, Aravantinou-Fatorou E, Tolia M, Giaginis C, Galanopoulos M, Kiakou M, Kostakis ID, Dana E, Vamvakaris I, Korogiannos A, Tsiambas E, Salemis N, Kyrgias G, Karameris A, Theocharis S. Anticancer Res. 2017 Apr;37(4):1773-1778. doi: 10.21873/anticanres.11510. PMID: 28373440.
20. Submerged Goiter Proven to be Metastatic Infiltration of a Neuro-Endocrine Merkel Cell Carcinoma.Tsoukalas Ν, Zoulamoglou Μ, Tolia Μ, Bournakis Ε, Ronne Ε, Barbounis V. Springer Plus. 2014;3:46
21. Clinical significance of cannabinoid receptors CB1 and CB2 expression in human malignant and benign thyroid lesions. E Lakiotaki, C Giaginis, M Tolia, P Alexandrou, I Delladetsima, I Giannopoulou, G Kyrgias, E Patsouris, S Theocharis. Biomed Res Int. 2015;2015:839403. doi: 10.1155/2015/839403.
22. Adjuvant chemotherapy and acute toxicity in hypofractionated radiotherapy for early breast cancer. Kouloulias V, Zygogianni A, Kypraiou E, Georgakopoulos J, Thrapsanioti Z, Beli I, Mosa E, Psyrri A, Antypas C, Armbilia C, Tolia M, Platoni K, Papadimitriou C, Arkadopoulos N, Gennatas C, Zografos G, Kyrgias G, Dilvoi M, Patatoucas G, Kelekis N, Kouvaris J. World J Clin Cases. 2014 Nov 16;2(11):705-10. doi: 10.12998/wjcc.v2.i11.705. PMID: 25405195; PMCID: PMC4233416.
23. Prognostic Significance of Serum Inflammatory Response Markers in Newly Diagnosed Non-Small Cell Lung Cancer before Chemoirradiation. Tolia M, Tsoukalas N, Kyrgias G, Mosa E, Maras A, Kokakis I, Liakouli Z, Kouvaris JR, Liaskonis K, Charalampakis N, Pistevou-Gombaki K, Kelekis N, Kouloulias V. Bio med Res Int. 2015;2015:485732. doi: 10.1155/2015/485732.
24. Prognostic Value of MRS Metabolites in Postoperative Irradiated High Grade Gliomas. Tolia M, Verganelakis D, Tsoukalas N, Kyrgias G, Papathanasiou M, Mosa E, Kokakis I, Kouvaris JR, Pissakas G, Pistevou-Gombaki K, Kelekis N, Kouloulias V. Biomed Res Int. 2015;2015:341042. doi: 10.1155/2015/341042.
25. Cancer immunotherapy: A different approach to the treatment of neoplastic disease. M. Κiakou, Μ.Tolia, Ν. Tsoukalas. Archives of Hellenic Medicine. 2015; 32(4):461-446.
26. Hypofractionated Irradiation for gliomas with 45.5Gy in 13 fractions: a retrospective study. Kouloulias V, Zygogianni A, Kouvaris J, Platoni P, Georgakopoulos J, Boviatsis E, Beli I, Tolia M, Antypas C, Karaiskos P, Scarleas C, Asimakopoulos C, Pantelakos P, Kelekis N. J Neurosurg Sci. 2015; 59(4):447-453.
27. Skin metastases of vulvar squamous cell carcinoma. Presentation of a rare case and review of the current literature.Sofoudis Chr, Tolia M, Salakos N,Kouvaris I, Fragoulidis G. Eur J Gynaecol Oncol. 2016;37(1):126-128.
28. Rectal neuroendocrine tumor with uncommon metastatic spread: A case report and review of literature.Tsoukalas N, Galanopoulos M, Tolia M, Kiakou M, Nakos G, Papakostidi A, Koumakis G. World J Gastrointest Oncol 2016; 8(2): 231-234
29. A Retrospective Analysis of Toxicity and Efficacy for 2 Hypofractionated Irradiation SchedulesVersus a Conventional One for Post-Mastectomy Adjuvant Radiotherapy in Breast Cancer.Kouloulias V, Mosa E, Zygogianni A, Kypraiou E, Georgakopoulos J, Platoni K, Antypas C, Kyrgias G, Tolia M, Papadimitriou C, Psyrri A, Patatoukas G, Dilvoi M, Armpilia C, Theodorou K, Kalogeridi M-A, Beli I, Kouvaris J, Kelekis N. Breast Care 2016;11:328-332.
30. Intraoperative radiation therapy (IORT) in head and neck cancer: A systematic review. Kyrgias G, Hajiioannou J, Tolia M, Kouloulias V, Lachanas V, Skoulakis C, Skarlatos I, Rapidis A, Bizakis I.Medicine (Baltimore). 2016;95(50):e5035.
31. Primary extramammary invasive Paget’s vulvar disease: what is the standard, what are the challenges and what is the future for radiotherapy? Tolia M, Tsoukalas N, Sofoudis C, Giaginis C, Spyropoulou D, Kardamakis D, Kouloulias V, Kyrgias G. BMC Cancer. 2016;16:563.
32. Validity and reliability of the Greek version of the xerostomia questionnaire in head and neck cancer patients. Memtsa PT, Tolia M, Tzitzikas I, Bizakis I, Pistevou-Gombaki K, Charalambidou M, Iliopoulou C, Kyrgias G. Support Care Cancer. 2016.1–7.
33. Metastatic Breast Carcinoma to the Pituitary Gland that Presented as Diabetes Insipidus: A Case Report. I Samaras, K Tsapakidis, E Maragouli, E Sogka, I Litos,M Tolia, VN Papadopoulos, K Papacharalampous, G Kyrgias, GK Koukoulis, G Papatsimpas. J Cancer Prev Curr Res. 2017, 8(2): 00273.
34. Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: A review of literature. Galanopoulos M, Tsoukalas N, Papanikolaou IS, Tolia M, Gazouli M, Mantzaris GJ. World J Gastrointest Oncol. 2017;9(4): 142-193.
35. Assessment of xerostomia and its impact on quality of life in head and neck cancer patients undergoing radiation therapy. Memtsa PT, Tolia M,Tzitzikas I, Bizakis J, Pistevou-Gombaki K, Charalambidou M, Iliopoulou C, Kyrgias G. Mol Clin Oncol. 2017;6(5):789-793.
36. Solitary Axillary Lymph Nodal Metastasis from Primary Ovarian Cancer: An Unusual Presentation. I Nazos, M Tolia*, Chr Sofoudis, N Tsoukalas, V Gougoutsi, G Vakis, G Kyrgias. Eur J Gynaecol Oncol. 2017;38(5):813-814. doi: 10.12892/ejgo3725.201.
37. Epithelial-Mesenchymal Transition in Non Small-cell Lung Cancer.Tsoukalas N, Aravantinou-Fatorou E, Tolia M*, Giaginis C, Galanopoulos M, Kiakou M, Kostakis ID, Dana E, Vamvakaris I, Korogiannos A, Tsiambas E, Salemis N, Kyrgias G, Karameris A, Theocharis S. Anticancer Res. 2017;37(4):1773-1778.
38. Malignant central nervous system tumors among adolescents and young adults (15-39 years old) in 14 Southern-Eastern European registries and the US Surveillance, Epidemiology, and End Results program: Mortality and survival patterns.
Georgakis MK, Papathoma P, Ryzhov A, Zivkovic-Perisic S, Eser S, Taraszkiewicz Ł, Sekerija M, Žagar T, Antunes L, Zborovskaya A, Bastos J, Florea M, Coza D, Demetriou A, Agius D, Strahinja RM, Themistocleous M, Tolia M, Tzanis S, Alexiou GA, Papanikolaou PG, Nomikos P, Kantzanou M, Dessypris N, Pourtsidis A, Petridou ET. Cancer. 2017;123(22): 4458-4471.
39. Higher adherence to Mediterranean diet prior to pregnancy is associated with decreased risk for deviation from the maternal recommended gestational weight gain. Koutelidakis AE, Alexatou O, Kousaiti S, Gkretsi E, Vasios G, Sampani A, Tolia M, Kiortsis DN, Giaginis C. Int J Food Sci Nutr. 2017;14:1-9.
40. An Exploratory Study of Radiation Dermatitis in Breast Cancer Patients. Alexopoulou E, Katsila T, Tolia M, Tsoukalas N, Leontsinidis M, Kyrgias G, Kouloulias V, Patrinos GP, Spyropoulou D, Kardamakis D. Anticancer Res. 2018;38(3):1615-1622.
41. Advances on systemic treatment for lung neuroendocrine neoplasms. N Tsoukalas, P Baxevanos, E Aravantinou-Fatorou, M Tolia, M Galanopoulos, K. Tsapakidis, G Kyrgias, C Toumpanakis, G Kaltsas. Ann Transl Med. 2018;6(8):145.
42. Advanced small cell lung cancer (SCLC): new challenges and new expectations. N Tsoukalas, E Aravantinou-Fatorou, P Baxevanos, M Tolia, K Tsapakidis, M Galanopoulos, M Liontos, G Kyrgias. Ann Transl Med. 2018;6(8):145.
43. Mucinous breast carcinoma with tall columnar cells.Tsoukalas N, Kiakou M, Tolia M, Kostakis ID, Galanopoulos M, Nakos G, Tryfonopoulos D, Kyrgias G, Koumakis G. Ann R Coll Surg Engl. 2018:e1-e4. doi: 10.1308/rcsann.2018.0060
44. Utilizing Yoga in oncologic patients treated with Radiotherapy: Review. M Tolia, N Tsoukalas, M Nikolaou, E Mosa, I Nazos, K Tsanadis, A Poultsidi, J Hajiioannou, D Spyropoulou, N Charalampakis, D Kardamakis, V Kouloulias, K Pistevou-Gombaki, G Kyrgias.Indian Journal of Palliative Care. 2018; 24(3): 355-358. doi: 10.4103/IJPC.IJPC_112_17.
45. Estimating the agreement between the metabolic rate calculated from prediction equations and from a portable indirect calorimetry device: an effort to develop a new equation for predicting resting metabolic rate. Pavlidou E, Petridis D, Tolia M, Tsoukalas N, Poultsidi A, Fasoulas A, Kyrgias G, Giaginis C. Nutr Metab (Lond). 2018 Jun 15;15:41. doi: 10.1186/s12986-018-0278-7. eCollection 2018.
46. Occipital Headache as Initial Manifestation of a Pancreatic Neuroendocrine Tumor. Tsoukalas N, Triantafyllidis A, Tolia M, Galanopoulos M, Kostakis ID, Demiri S, Toumpanakis C, Koumakis G. J Gastrointest Cancer. 2017. doi: 10.1007/s12029-017-9931-z.
47. Medical management of gastric cancer: a 2017 update.Charalampakis N, Economopoulou P, Kotsantis I, Tolia M, Schizas D, Liakakos T, Elimova E, Ajani JA, Psyrri A. Cancer Med. 2017 Dec 13. doi: 10.1002/cam4.1274.
48. Preoperative factors affecting the intraoperative core body temperature in elective hysterectomy under general anesthesia. E Chalari, G Intas, S Zyga, G Fildissis, M Tolia, N Tsoukalas, A Yfantis, G Kyrgias, G Panoutsopoulos. Clinical and experimental obstetrics & gynecology. 2019;(4):560-564. DOI: 10.12891/ceog4616.2019.
49. Systemic therapy of metastatic renal cell carcinoma: Review of the current literature. Zerdes I, Tolia M*, Tsoukalas N, Mitsis M, Kardamakis D, Pistevou-Gombaki K, Tsekeris P, Kyrgias G. Urologia. 2018 Oct 1:391560318802166.
50. Immunotherapy of Cancer. Developments and Reference Points, an Unorthodox Approach. Integrative Cancer Therapies. Nikolaou M, Nikolaou G, Digklia A, Pontas C, Tsoukalas N, Kyrgias G, Tolia M. Integrative Cancer Therapies. 2019; 18(1): 1 –10.doi: 10.1177/1534735419827090.
51. Breast Radiotherapy and Early Adverse Cardiac Effects. The Role of Serum Biomarkers and Strain Echocardiography. A.Gkantaifi, C. Papadopoulos, D. Spyropoulou, M. Toumpourleka, G. Iliadis, D. Kardamakis, M. Nikolaou, N. Tsoukalas, G. Kyrgias, M. Tolia. Anticancer Res. 2019; 39(4):1667-1673. doi: 10.21873/anticanres.13272.
52. Perioperative inadvertent hypothermia among urology patients who underwent transurethral resection with either TURis or TURP method. E Chalari, G Intas, S Zyga, G Fildissis, M Tolia, Chr Toutziaris, N Tsoukalas, G Kyrgias, G Panoutsopoulos. Urologia. 2019;86(2):69-73. doi: 10.1177/0391560318758937.
53. Acute Leriche Syndrome in pancreatic adenocarcinoma: A case report. E. Mosa, S. Manouvelou, M. Tolia*, N. Tsoukalas, A. Ardavanis, M. Stasinopoulou, G. Kyrgias, A. Tavernaraki. Curr Med Imaging. 2020;16(5):622-624. doi: 10.2174/1573405615666190206161013.
54. Differential diagnosis of behavioral variant and semantic variant of Frontotemporal Dementia using visual rating scales. S. Manouvelou, V. Koutoulidis, I. Tsougos, M. Tolia, G. Kyrgias, G. Anyfantakis, L-A Moulopoulos, A. Gouliamos, SG. Papageorgiou. Curr Med Imaging. 2020;16(4):444-451. doi: 10.2174/1573405615666190225154834.
55. Primary Gross Tumor Volume (pGTV) and Tumor Response in Locally Advanced Rectal Cancer (LARC). Is There Any Correlation? Tsoukalas N, Mosa E, Tsapakidis K, Kamposioras K, Tolia M. J Invest Surg. 2019 Aug 19:1-3. doi: 10.1080/08941939.2019.1650988.
56. Benign Intracranial Lesions – Radiotherapy: An Overview of Treatment Options, Indications and Therapeutic Results. Tzikoulis V, Gkantaifi A, Alongi F, Tsoukalas N, Saraireh HH, Charalampakis N, Tzikoulis G, Andreou E, Tsapakidis K, Kardamakis D, Tsanadis K, Kyrgias G, Tolia M. Rev Recent Clin Trials. 2019 Nov 10. doi: 10.2174/1574887114666191111100635.
57. Desmoplastic small round-cell tumour of the peritoneal cavity: case report and literature review. Tsoukalas N, Kiakou M, Nakos G, Tolia M, Galanopoulos M, Tsapakidis K, Kamposioras K, Christofyllakis C, Dimitrakopoulos G, Sambaziotis D. Ann R Coll Surg Engl. 2020 Jan 24:1-5. doi: 10.1308/rcsann.2019.0180.
58. Current and future aspects of TIM-3 as biomarker or as potential targeted in non-small cell lung cancer scope: is there a role in clinical practice? R Andrade De Mello, J-H Zhu, J Iavelberg, A-H Potim, D Simonetti, J-A Silva Júnior, P Castelo-Branco, D-H Pozza, C Chizuru Tajima, M Tolia, G Antoniou. Transl Lung Cancer Res 2020 | http://dx.doi.org/10.21037/tlcr-20-625.
59. Can Bioelectrical Impedance Analysis and BMI be a Prognostic Tool in Head and Neck Cancer Patients? A Review of the Evidence. Mantzorou M, Tolia M, Poultsidi A, Pavlidou E, Papadopoulou SK, Papandreou D, Giaginis C. Cancers (Basel). 2020;12(3):557. doi: 10.3390/cancers12030557.
60. Perioperative radiotherapy versus surgery alone for retroperitoneal sarcomas: a systematic review and meta-analysis. Diamantis A, Baloyiannis I, Magouliotis DE, Tolia M, Symeonidis D, Bompou E, Polymeneas G, Tepetes K. Radiol Oncol. 2020 Feb 29. pii: /j/raon.ahead-of-print/raon-2020-0012/raon-2020-0012.xml. doi: 10.2478/raon-2020-0012.
61. Real world data regarding the management of cancer-associated thrombosis. Tsoukalas N, Tsapakidis K, Galanopoulos M, Karamitrousis E, Kamposioras K, Tolia M. Curr Opin Oncol. 2020 Jul;32(4):289-294. doi: 10.1097/CCO.0000000000000646.
62. Summary of international recommendations in 23 languages for patients with cancer during the COVID-19 pandemic. Mauri D, Kamposioras K, Tolia M, Alongi F, Tzachanis D; International Oncology Panel and European Cancer Patient Coalition collaborators. Lancet Oncol. 2020 Jun;21(6):759-760. doi: 10.1016/S1470-2045(20)30278-3.
63. Evaluation of the Irradiated Volume of the Heart and Cardiac Substructures After Left Breast Radiotherapy. Gkantaifi A, Papadopoulos C, Spyropoulou D, Toumpourleka M, Iliadis G, Tsoukalas N, Kyrgias G, Tolia M. Anticancer Res. 2020 May;40(5):3003-3009. doi: 10.21873/anticanres.14281.
64. Oligometastasis and local ablation in the era of systemic targeted and immunotherapy. Mazzola R, Jereczek-Fossa BA, Franceschini D, Tubin S, Filippi AR, Tolia M, Lancia A, Minniti G, Corradini S, Arcangeli S, Scorsetti M, Alongi F. Radiat Oncol. 2020 May 4;15(1):92. doi: 10.1186/s13014-020-01544-0.
65. Stereotactic body radiotherapy (SBRT) can delay polymetastatic conversion in patients affected by liver oligometastases. Nicosia L, Cuccia F, Mazzola R, Figlia V, Giaj-Levra N, Ricchetti F, Rigo M, Bonù M, Corradini S, Tolia M, Alongi F. J Cancer Res Clin Oncol. 2020 Apr 30. doi: 10.1007/s00432-020-03223-9.
66. Patient and family support in the era of fake e-medicine: food for thought from an international consensus panel. Mauri D, Kamposioras K, Tzachanis D, Tolia M, Valachis A, Dambrosio M, Alongi F, De Mello RA, Lövey J, Anthoney A, Christopoulos C, Saraireh HH, Kountourakis P, Kampletsas E, Tsali L, Tsakiridis T, Kosovitsas I, Soukovelos A, Lymperatou D, Polyzos N, Zarkavelis G. ESMO Open. 2020 Apr;5(2):e000696. doi: 10.1136/esmoopen-2020-000696.
67. Impact of Radiation Therapy on pain relief of cancer patients affected by on Malignant Psoas Syndrome: 26 years of experience. A Gerontopoulos, E Mosa, F Alongi, I Kokakis, H-H Saraireh, N Tsoukalas, N Charalampakis, K Tsanadis, K Tsapakidis, Ε Maragkouli, C Christopoulos, M Tolia. Indian J Palliat Care. 2020 Jul-Sep;26(3):348-351. doi: 10.4103/IJPC.IJPC_205_19.
68. Honey against radiation induced oral mucositis in head and neck cancer patients. An Umbrella Review of Systematic Reviews and Meta-Analyses of the literature. Gkantaifi A, Alongi F, Vardas E, Cuccia F, Hajiioannou J, Kyrodimos E, Christopoulos C, Mauri D, Charalampakis N, Trogkanis N, Tsoukalas N, Iliadis G, Tolia M. Rev Recent Clin Trials. 2020 Jul 9. doi: 10.2174/1574887115666200709140405.
69. Radiation Induced Oral Mucositis in Head and Neck Cancer Patients. Is There Any Effective Management? Review of the Literature the Last Five Years. Gkantaifi A, Vardas E, Alongi F, Tsoukalas N, Saraireh HH, Charalampakis N, Jozsef L, Hajiioannou J, Kyrodimos E, Tsanadis K, Davide M, Christos C, Iliadis G, Tolia M. Rev Recent Clin Trials. 2020 Jul 31. doi: 10.2174/1574887115666200731182708.
70. How breast cancer treatments affect the quality of life of women with non-metastatic breast cancer one year after surgical treatment: a cross-sectional study in Greece. Yfantis A, Sarafis P, Moisoglou I, Tolia M, Intas G, Tiniakou I, Zografos K, Zografos G, Constantinou M, Nikolentzos A, Kontos M. BMC Surg. 2020;20(1):210. doi: 10.1186/s12893-020-00871-z.
71. Oncologic Children Undergoing Radiotherapy: Ways to Alleviate the Psychological Burden. Review. Skoutari A, Chounta E, Skenteris N, Tsoukalas N, Alexopoulou A, Tolia M. Rev Recent Clin Trials. 2020 Oct 1. doi: 10.2174/1574887115666201001141936.
72.Modern radiopharmaceuticals for lung cancer imaging with positron emission tomography/computed tomography scan: A systematic review. Theodoropoulos AS, Gkiozos I, Kontopyrgias G, Charpidou A, Kotteas E, Kyrgias G, Tolia M. SAGE Open Med. 2020 Sep 28;8:2050312120961594. doi: 10.1177/2050312120961594. eCollection 2020.
73. Upper Gastrointestinal Cancer Management in the COVID-19 Era: Risk of Infection, Adapted Role of Endoscopy, and Potential Treatment Algorithm Alterations. Apostolou K, Vogli S, Frountzas M, Syllaios A, Tolia M, Papanikolaou IS, Schizas D. J Gastrointest Cancer. 2020 Nov 26:1-7. doi: 10.1007/s12029-020-00557-y.
74. Synthesis of Recommendations From 25 Countries and 31 Oncology Societies: How to Navigate Through Covid-19 Labyrinth. Kamposioras K, Mauri D, Papadimitriou K, Anthoney A, Hindi N, Petricevic B, Dambrosio M, Valachis A, Kountourakis P, Kopecky J, Kuhar CG, Popovic L, Chilingirova NP, Zarkavelis G, de Mello RA, Plavetić ND, Christopoulos C, Mostert B, Goffin JR, Tzachanis D, Saraireh HH, Ma F, Pavese I, Tolia M. Front Oncol. 2020 Nov 19;10:575148. doi: 10.3389/fonc.2020.575148. eCollection 2020.
75. The role of radiotherapy in patients with solid tumours after solid organ transplantation: a systematic review. Mazzola R, Cuccia F, Bertani A, Tubin S, Conaldi PG, Corradini S, Tolia M, Guba M, Alongi F. Lancet Oncol. 2021 Mar;22(3):e93-e104. doi: 10.1016/S1470-2045(20)30590-8. PMID: 33662300.
76. Potential role of immunotherapy for advanced breast cancer. de Mello RA, Amaral GA, Tajima CC, Tadokoro H, Iavelberg J, Simonetti D, Tolia M, Silva JA. Immunotherapy. 2021 Apr 7. doi: 10.2217/imt-2021-0037.
77. Radiotherapy and Renal Cell Carcinoma: A Continuing Saga. Spyropoulou D, Tsiganos P, Dimitrakopoulos FI, Tolia M, Koutras A, Velissaris D, Lagadinou M, Papathanasiou N, Gkantaifi A, Kalofonos H, Kardamakis D. In Vivo. 2021 May-Jun;35(3):1365-1377. doi: 10.21873/invivo.12389. Epub 2021 Apr 28. PMID: 33910814
78. Risk for second bladder and rectal malignancies from cervical cancer irradiation. Mazonakis M, Lyraraki E, Tolia M, Damilakis J. J Appl Clin Med Phys. 2021 May 21. doi: 10.1002/acm2.13274. Epub ahead of print. PMID: 34021692.
79. Immunotherapy for cholangiocarcinoma: a 2021 update. Charalampakis N, Papageorgiou G, Tsakatikas S, Fioretzaki R, Kole C, Kykalos S, Tolia M, Schizas D. Immunotherapy. 2021 Jun 30. doi: 10.2217/imt-2021-0126. Epub ahead of print. PMID: 34190581.
80. Metastatic rectal cancer in the ampulla of Vater: A unique case. Samara AA, Sgantzou IK, Diamantis A, Kokkalis A, Tsapakidis K, Tolia M, Christodoulidis G, Rountas C, Zacharoulis D. Cancer Rep (Hoboken). 2021 Jul 17:e1510. doi: 10.1002/cnr2.1510. Epub ahead of print. PMID: 34272839.
81. Cutaneous soft tissue sarcomas: survival-related factors. Gkantaifi A, Diamantis A, Mauri D, Nixon I, Kyriazoglou A, Baloyiannis I, Tsoukalas N, Charalampakis N, Schizas D, Cuccia F, Alongi F, de Mello RA, Iliadis G, Kamposioras K, Mazonakis M, Tolia M. Arch Dermatol Res. 2021 Jul 17. doi: 10.1007/s00403-021-02268-1. Epub ahead of print. PMID: 34272971.
82. Current and potential biomarkers in gastric cancer: a critical review of the literature. de Mello RA, Amaral GA, Neves NM, Lippo EG, Parini F, Xu S, Tolia M, Charalampakis N, Tadokoro H, Castelo-Branco P, Zhu J. Future Oncol. 2021 Jul 22. doi: 10.2217/fon-2021-0084. Epub ahead of print. PMID: 34291647.
83. Immunotherapy for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a 2021 update. Kole C, Charalampakis N, Vailas M, Tolia M, Sotiropoulou M, Tsakatikas S, Kouris NI, Tsoli M, Koumarianou A, Karamouzis MV, Schizas D. Cancer Immunol Immunother. 2021 Sep 1. doi: 10.1007/s00262-021-03046-8.
84. Immunotherapy Efficacy in the Initial Lines of Treatment in Advanced Upper Gastrointestinal Malignancies: A Systematic Review of the Literature. Kamposioras K, Ntellas P, Nikolaou M, Germetaki T, Gazouli I, Dadouli K, Zarkavelis G, Amylidi AL, Tolia M, Mauri D. JNCI Cancer Spectr. 2021 Nov 16;5(6):pkab088. doi: 10.1093/jncics/pkab088. PMID: 34926989; PMCID: PMC8677514.
85. YAP/Hippo Pathway and Cancer Immunity: It Takes Two to Tango. Matthaios D, Tolia M, Mauri D, Kamposioras K, Karamouzis M. Biomedicines. 2021 Dec 20;9(12):1949. doi: 10.3390/biomedicines9121949. PMID: 34944765; PMCID: PMC8698579.
86. COVID-19 Vaccinations: Summary Guidance for Cancer Patients in 28 Languages: Breaking Barriers to Cancer Patient Information. Davide M, Kamposioras K, Lampriani T, Mario D, Berardino B, Nadia H, Carl S, Joanna N, Dimitrios T, Flippo A, Hassan H, Antonios V, Konstantinos P, Stefanie C, Lazar P, Jindrich K, Andres R, Katarina A, Junlin Y, Lovey J, Primoz S, Haytham S, Ranveig R, Marzanna C, Olalla SC, Natalia C, Ramon A M, Giovanna AA, Farsid A, Radu V, Erjeta R, D T, Chirstos C, Irina I, Igor D, Branka P, Francesco C, Iglika M, Natalija DP, Cvetka GK, Elena T, Pantelis K, Panagiotis N, Ioanna G, Stefania G, Salih Y, Er Ö, Yasmina C, Kumaran G, Orges S, Aasim Y, Gono P, Apostolidis K, Tolia M. Rev Recent Clin Trials. 2021 Oct 28. doi: 10.2174/1574887116666211028145848.
87. Next Generation Sequencing of Circulating Tumor DNA Can Optimize Second Line Treatment in RAS Wild Type Metastatic Colorectal Cancer after Progression on Anti-EGFR Therapy: Time to Rethink Our Approach. Mauri D, Kamposioras K, Matthaios D, Tolia M, Nixon I, Dambrosio M, Zarkavelis G, Papadimitriou K, Petricevic B, Kountourakis P, Kopecky J, Grašič Kuhar C, Popovic L, Chilingirova NP, De Mello RA, Dedic N, Katsanos K, Mostert B, Alongi F, de Bari B, Corradini S, Kampletsas E, Gazouli I, Gkoura S, Amylidi AL, Valachis A. Oncol Res Treat. 2022 Jan 9. doi: 10.1159/000521845.
88. Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease. Kibbi N, Owen JL, Worley B, Wang JX, Harikumar V, Downing MB, Aasi SZ, Aung PP, Barker CA, Bolotin D, Bordeaux JS, Cartee TV, Chandra S, Cho NL, Choi JN, Chung KY, Cliby WA, Dorigo O, Eisen DB, Fujisawa Y, Golda N, Halfdanarson TR, Iavazzo C, Jiang SIB, Kanitakis J, Khan A, Kim JYS, Kuzel TM, Lawrence N, Leitao MM Jr, MacLean AB, Maher IA, Mittal BB, Nehal KS, Ozog DM, Pettaway CA, Ross JS, Rossi AM, Servaes S, Solomon MJ, Thomas VD, Tolia M, Voelzke BB, Waldman A, Wong MK, Zhou Y, Arai N, Brackett A, Ibrahim SA, Kang BY, Poon E, Alam M. JAMA Oncol. 2022 Jan 20. doi: 10.1001/jamaoncol.2021.7148. Epub ahead of print. PMID: 35050310.
89. Molecular regulatory mechanism of ferroptosis and its role in gastrointestinal oncology: Progress and updates. Fan Yang, Si-Yu Sun, Sheng Wang, Jin-Tao Guo, Xiang Liu, Nan Ge, Guo-Xin Wang, M Li, D Kaili, L Shi, NJ Murugan, IA Voutsadakis, YC Kuo, LY Yu, HY Wang, MJ Chen, MS Wu, CJ Liu, YC Lin, SC Shih, KC Hu, HY Sun, Li YY Du ST, GT Deng, FR Zeng, SY Tang, PJ Zhou, Y Meng, N Uemura, H Hayashi, H Baba, F Liang, K Zhang, TJ Liu, JN Li, B Uhl, KT Prochazka, K Fechter, K Pansy, HT Greinix, P Neumeister, AJ Deutsch, Y Luo, F Teng, H Fu, GS Ding, N Charalampakis, S Tsakatikas, D Schizas, S Kykalos, M Tolia, R Fioretzaki, G Papageorgiou, I Katsaros, AAF Abdelhakeem, M Sewastjanow-Silva, JE Rogers, JA Ajani, R Hendriquez, T Keihanian, J Goyal, RR Abraham, R Mishra, M Girotra. World Journal of Gastrointestinal Oncology (2022).
90. Vaginal dilator use to promote sexual wellbeing after radiotherapy in gynecological cancer survivors. Charatsi D, Vanakara P, Evaggelopoulou E, Simopoulou F, Korfias D, Daponte A, Kyrgias G, Tolia M. Medicine (Baltimore). 2022 Jan 28;101(4):e28705. doi: 10.1097/MD.0000000000028705.
91. Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives. Charalampakis N, Tsakatikas S, Schizas D, Kykalos S, Tolia M, Fioretzaki R, Papageorgiou G, Katsaros I, Abdelhakeem AAF, Sewastjanow-Silva M, Rogers JE, Ajani JA. World J Gastrointest Oncol. 2022 Jan 15;14(1):181-202. doi: 10.4251/wjgo.v14.i1.181. PMID: 35116110; PMCID: PMC8790425.
92. Radiotherapy and breast reconstruction: What is the ideal timing? A narrative review. Letsiou E, Tsakatikas S, Vakis G, Tsapakidis K, Charalampakis N, Diamantis A, Poultsidi A, Michelakis D, de Bree E, Mauri D, Tsoukalas N, Antoniades C, Tolia M. Rev Recent Clin Trials. 2022 Mar 14. doi: 10.2174/1574887117666220314161609.
93. Evaluation of diagnostic algorithm and therapeutic interventions for intra-abdominal desmoid tumors. Mastoraki A, Schizas D, Vassiliu S, Saliaris K, Giagkos GC, Theochari M, Vergadis C, Tolia M, Vassiliu P, Felekouras E. Surg Oncol. 2022 May;41:101724. doi: 10.1016/j.suronc.2022.101724.
94. Adherence to Mediterranean Diet and Nutritional Status in Women with Breast Cancer: What Is Their Impact on Disease Progression and Recurrence-Free Patients’ Survival? M Mantzorou, M Tolia, A Poultsidi, GK Vasios, D Papandreou, S Theocharis, N Kavantzas, AY Troumbis, C Giaginis. Curr Oncol. 2022 Oct 6;29(10):7482-7497. doi: 10.3390/curroncol29100589.
95. 3D-CRT, IMRT and VMAT for flank irradiation due to pediatric Wilms tumor: A comparative planning study with XCAT phantoms. Mazonakis M, Lyraraki E, Tolia M, Damilakis J. Phys Med. 2022 Oct 15;103:89-97. doi: 10.1016/j.ejmp.2022.10.002.
96. Childhood overweight and obesity and abnormal birth anthropometric measures are associated with a higher prevalence of childhood asthma in pre-school age. Pavlidou E, Mantzorou M, Tolia M, Antasouras G, Poutsidi A, Psara E, Poulios E, Fasoulas A, Vasios GK, Giaginis C. J Asthma. 2022 Nov 4:1-17. doi: 10.1080/02770903.2022.2144354.
97. COVID-19 Emotional and Mental Impact on Cancer Patients Receiving Radiotherapy: An Interpretation of Potential Explaining Descriptors. Tolia M, Symvoulakis EK, Matalliotakis E, Kamekis A, Adamou M, Kountourakis P, Mauri D, Dakanalis A, Alexidis P, Varveris A, Antoniadis C, Matthaios D, Paraskeva M, Giaginis C, Kamposioras K. Current Oncology. 2023; 30(1):586-597. https://doi.org/10.3390/curroncol30010046.
98. A Proposed Nomogram Model for Recurrence of Non-Muscle Invasive Bladder Carcinoma. Tsapakidis K, Liontos M, Tolia M, Tsoukalas N. J Invest Surg. 2022 Jul;35(7):1610-1611. doi: 10.1080/08941939.2022.2071507.
99. Radiation-Induced Esophageal Cancer: Investigating the Pathogenesis, Management, and Prognosis. Syllaios A, Vailas M, Tolia M, Charalampakis N, Vlachos K, Kapetanakis EI, Tomos PI, Schizas D. Medicina (Kaunas). 2022 Jul 18;58(7):949. doi: 10.3390/medicina58070949.
100. Cancer patient care during different war times; is the response too slow? Tolia M, Kamposioras K, Symvoulakis EK, Mauri D, Skouras P, Schizas D, Charalampakis N, Kokakis I, Matthaios D, Gazouli I, Ferentinos K, Girvalaki C, Apostolidis K. ESMO Open. 2022 Aug;7(4):100557. doi: 10.1016/j.esmoop.2022.100557.
101. Interior Design: A New Perspective in Supportive Care of Patients with Acute Onset of Debilitating Diseases. Mauri D, Kampletsas E, Smyris G, Tsali L, Tsekeris P, Harissis H, Kamposioras K, Tolia M, Hyphantis T, Ntellas P, Gazouli I, Zarkavelis G, Mavroeidis L, Amylidi AL, Torounidou N, Gogadis A, Nixon J. Palliat Med Rep. 2021 Dec 27;2(1):365-368. doi: 10.1089/pmr.2021.0031.
102. Hyperthermic intraperitoneal chemotherapy (HIPEC) for the management of primary advanced and recurrent ovarian cancer: a systematic review and meta-analysis of randomized trials. Filis P, Mauri D, Markozannes G, Tolia M, Filis N, Tsilidis K. ESMO Open. 2022 Oct;7(5):100586. doi: 10.1016/j.esmoop.2022.100586.
103. Superficial soft tissue sarcomas: 10 year survival outcomes. Tolia M, Gkantaifi A, Hayward L, Gupta G, Kyriazoglou A, Mauri D, Nixon I. Superficial soft tissue sarcomas: 10 year survival outcomes. Oncol Lett. 2023 Jan 27;25(3):96. doi: 10.3892/ol.2023.13682.
104. Immune checkpoint inhibitors and combinations with other agents in cholangiocarcinoma. Skouteris N, Papageorgiou G, Fioretzaki R, Charalampakis N, Schizas D, Kykalos S, Tolia M. Immunotherapy. 2023 Mar 6. doi: 10.2217/imt-2022-0225.
105. Maternal Gestational Diabetes Is Associated with High Risk of Childhood Overweight and Obesity: A Cross-Sectional Study in Pre-School Children Aged 2-5 Years. Mantzorou M, Papandreou D, Pavlidou E, Papadopoulou SK, Tolia M, Mentzelou M, Poutsidi A, Antasouras G, Vasios GK, Giaginis C. Medicina (Kaunas). 2023 Feb 24;59(3):455. doi: 10.3390/medicina59030455.
106. Current Cardioprotective Strategies for the Prevention of Radiation-Induced Cardiotoxicity in Left-Sided Breast Cancer Patients. Nikovia V, Chinis E, Gkantaifi A, Marketou M, Mazonakis M, Charalampakis N, Mavroudis D, Orfanidou KV, Varveris A, Antoniadis C, Tolia M. J Pers Med. 2023 Jun 24;13(7):1038. doi: 10.3390/jpm13071038. PMID: 37511651; PMCID: PMC10381791.
107. Metformin: A Promising Radiosensitizer in Neoadjuvant Rectal Cancer Treatment. Georgopoulos NS, Tolia M*, Mauri D, Kamposioras K, Charalampakis N, Tsoukalas N, Gkantaifi A. Rev Recent Clin Trials. 2023 Apr 28. doi: 10.2174/1574887118666230428114349.
*Θεωρούμαι πρώτος συγγραφέας, γιατί οι πρώτοι δυο είχαν την ίδια συνεισφορά.
108. NTCP Calculations of Five Different Irradiation Techniques for the Treatment of Thymoma. Mazonakis M, Kachris S, Tolia M, Damilakis J. Curr Oncol. 2023 Aug 19;30(8):7740-7752. doi: 10.3390/curroncol30080561. PMID: 37623042; PMCID: PMC10453123.
109. Surgery and proton radiation therapy for pediatric base of skull chordomas: Long-term clinical outcomes for 204 patients. Ioakeim-Ioannidou M, Niemierko A, Kim DW, Tejada A, Urell T, Leahy S, Adams J, Fullerton B, Nielsen GP, Hung YP, Shih AR, Patino M, Buch K, Rincon S, Kelly H, Cunnane MB, Tolia M, Widemann BC, Wedekind MF, John L, Ebb D, Shin JH, Cote G, Curry W, MacDonald SM. Neuro Oncol. 2023 Sep 5;25(9):1686-1697. doi: 10.1093/neuonc/noad068. PMID: 37029730; PMCID: PMC10484173.
110. Intermittent Fasting against Cancer Development and Progression: Highlighting Potential Anticancer Molecular Mechanisms. Psara E, Poulios E, Papadopoulou SK, Tolia M, Vasios GK, Giaginis C. Anticancer Agents Med Chem. 2023; 23(17): 1889-1909. doi: 10.2174/1871520623666230816090229. PMID: 37587803.
111. Role of telomere length in human carcinogenesis (Review). Tsatsakis A, Oikonomopoulou T, Nikolouzakis TK, Vakonaki E, Tzatzarakis M, Flamourakis M, Renieri E, Fragkiadaki P, Iliaki E, Bachlitzanaki M, Karzi V, Katsikantami I, Kakridonis F, Hatzidaki E, Tolia M, Svistunov AA, Spandidos DA, Nikitovic D, Tsiaoussis J, Berdiaki A. Int J Oncol. 2023 Jul;63(1):78. doi: 10.3892/ijo.2023.5526.
112. Retroperitoneal Soft Tissue Sarcoma: Emerging Therapeutic Strategies. de Bree E, Michelakis D, Heretis I, Kontopodis N, Spanakis K, Lagoudaki E, Tolia M, Zografakis-Sfakianakis M, Ioannou C, Mavroudis D. Cancers (Basel). 2023 Nov 18;15(22):5469. doi: 10.3390/cancers15225469. PMID: 38001729; PMCID: PMC10670057.
113. TAMs and PD-1 Networking in Gastric Cancer: A Review of the Literature. Yerolatsite M, Torounidou N, Gogadis A, Kapoulitsa F, Ntellas P, Lampri E, Tolia M, Batistatou A, Katsanos K, Mauri D. Cancers (Basel). 2023 Dec 30;16(1):196. doi: 10.3390/cancers16010196. PMID: 38201623; PMCID: PMC10778110.
114. Radiation Dose to Critical Cardiac Structures from Three-Dimensional Conformal Radiation Therapy (3D-CRT), Intensity-Modulated Radiation Therapy (IMRT) and Volumetric Modulated Arc Therapy (VMAT) Techniques for Left-Sided Breast Cancer. Konstantinou E, Varveris A, Solomou G, Antoniadis C, Tolia M, Mazonakis M. J Pers Med. 2024 Jan 3;14(1):63. doi: 10.3390/jpm14010063. PMID: 38248764; PMCID: PMC10817491.
115. Robotic Stereotactic Body Radiation Therapy for Oligometastatic Liver Metastases: A Systematic Review of the Literature and Evidence Quality Assessment. Kyrochristou I, Giannakodimos I, Tolia M, Georgakopoulos I, Pararas N, Mulita F, Machairas N, Schizas D. Diagnostics (Basel). 2024 May 19;14(10):1055. doi: 10.3390/diagnostics14101055. PMID: 38786353.
116. Risk of Radiation-Induced Second Primary Cancers and Cardiotoxicity following Therapeutic Irradiation for Thymoma with Photon Beams: A Treatment Planning Study. Mazonakis M, Kachris S, Tolia M, Damilakis J. Applied Sciences. (2024);14(11):4926.
117. The Critical Role of the Early Evaluation of Iron and Vitamin B12 Deficiency in Pregnancy. Gοugοutsi V, Pouliakis A, Tsantes A, Tolia M, Nazos N-A, Panagopoulos P, Kokoris S. (August 23, 2024) Cureus 16(8): e67592. doi:10.7759/cureus.67592
118. Metastatic bone involvement in vulvar cancer: report of a rare case and review of the literature. Tolia M, Tsoukalas N, Platoni K, Dilvoi M, Pantelakos P, Kelekis N, Kouloulias V. Eur J Gynaecol Oncol. 2012;33(4):411-413.
119. Gastrointestinal Stromal Tumor (GIST) and Synchronous Intra-Abdominal Liposarcoma: A Report of Two Rare Cases and Literature Review. Diamantis A, Samara AA, Baloyiannis I, Symeonidis D, Diamantis AM, Tolia M, Bouliaris K, Koukoulis G, Tepetes K. Int J Surg Oncol. 2021 Sep 1;2021:2626635. doi: 10.1155/2021/2626635. PMID: 34518784; PMCID: PMC8434899.
120. Vaginal stenosis after radiation therapy for pelvic cancer: prevention and treatment options – a review of the current literature. D. Charatsi, M. Tolia*, P.Vanakara, N. Tsoukalas, M. Nikolaou, D. Korfias, G. Nikolaou, A. Daponte, G. Kyrgias. Eur. J. Gynaecol. Oncol. – ISSN: 0392-2936 XL, n. 2, 2019. doi: 10.12892/ejgo4496.2019
121. Pathologic complete response in patients with localized soft tissue sarcoma treated with neoadjuvant therapy and its correlation with clinical outcomes: A systematic review. Boulouta A, Kyriazoglou A, Kotsantis I, Economopoulou P, Anastasiou M, Pantazopoulos A, Kyrkasiadou M, Moutafi M, Gavrielatou N, Zazas E, Caglar C, Nixon I, Tolia M, Kavourakis G, Psyrri A. Cancer Treat Rev. 2024 Aug 24;130:102820. doi: 10.1016/j.ctrv.2024.102820. Epub ahead of print. PMID: 39216184.
122. Differential diagnosis of Alzheimer’s disease and vascular dementia using visual rating scales. S Manouvelou, A Gouliamos, V Koutoulidis, M Tolia, G Anyfantakis, L-A Moulopoulos, SG Papageorgiou. Hellenic Journal οf Radiology. 2020.
123. Diffuse pigmented villonodular synovitis of the knee joint: 3-year follow-up of a case report. A Koutalos, D Ragias, E Rizniotopoulos, K Tsanadis, E Xydias, N Tsoukalas, N Charalampakis, N Trogkanis, M Ioannou, KN. Malizos, M Tolia. Radiat Oncol J. 2022 Dec;40(4):270-275. doi: 10.3857/roj.2022.00122.
124. May Nutritional Status Positively Affect Disease Progression and Prognosis in Patients with Esophageal and Pharyngeal Cancers? A Scoping Review of the Current Clinical Studies. Antasouras G, Papadopoulou SK, Tolia M, Pandi AL, Spanoudaki M, Tsoukalas N, Tsourouflis G, Psara E, Mentzelou M, Giaginis C. Med Sci (Basel). 2023 Oct 2;11(4):64. doi: 10.3390/medsci11040064. PMID: 37873749; PMCID: PMC10594480.
125. Association of Mediterranean Diet Adherence with Disease Progression Characteristics, Lifestyle Factors and Overall Survival in Gastric Cancer Patients. Pavlidou E, Papadopoulou SK, Tolia M, Mentzelou M, Tsoukalas N, Alexatou O, Tsiouda T, Tsourouflis G, Psara E, Bikos V, Kavantzas N, Kotta-Loizou I, Dakanalis A, Vorvolakos T, Giaginis C. Med Sci (Basel). 2023 Nov 15;11(4):74. doi: 10.3390/medsci11040074. PMID: 37987329; PMCID: PMC10660706.
126. Synthesis and biological evaluation of novel cationic Rhenium and Technetium-99m complexes bearing quinazoline derivative for EGFR targeting. S Triantopoulou, I Roupa, A Shegani, NN Pirmettis, GI Terzoudi, A Chiotellis, M Tolia, J Damilakis, I Pirmettis, M Paravatou-Petsota. Pharmaceutics 16.9 (2024): 1213.
127. Synchronous diagnosis of testicular and thyroid cancer in a young male. Tsoukalas N, Kiakou M, Tolia M, Galanopoulos M, Tsapakidis K, Arvanitou E, Charalambakis N, Tountziaris V, Nikolaou M, Christofyllakis C. Exp Oncol. 2023 Oct 11;45(2):263-268. doi: 10.15407/exp-oncology.2023.02.263. PMID: 37824765.
128. Exosomal MicroRNA-223, MicroRNA-146, and MicroRNA-21 Profiles and Biochemical Changes in Laryngeal Cancer. Genc S, Yagci T, Vageli DP, Dundar R, Doukas PG, Doukas SG, Tolia M, Chatzakis N, Tsatsakis A, Taghizadehghalehjoughi A. ACS Pharmacol Transl Sci. 2023 Apr 24;6(5):820-828. doi: 10.1021/acsptsci.3c00038.
129. Proton-Based Radiation Therapy for Skull Base Chondrosarcomas in Children and Adolescents: 40-year experience from a single institution. Myrsini Ioakeim-Ioannidou, Saveli Goldberg, Tobias Urell, Athena Tejada, G. Petur Nielsen, Yin P. Hung, Judith Adams, Barbara Fullerton, Paul Caruso, Manuel Patino, Karen Buch, Sandra Rincon, Osamu Sakai, Maria Tolia, David Ebb, Gregory Cote, William Curry, Drosoula Giantsoudi, Shannon M. MacDonald. Int J Radiat Oncol Biol Phys. 2024 Sep 18:S0360-3016(24)03401-1. doi: 10.1016/j.ijrobp.2024.09.030.
130. Recommended Guidelines for Screening for Underlying Malignancy in Extramammary Paget’s Disease Based on Anatomic Subtype. Kibbi N, Owen JL, Worley B, Alam M; Extramammary Paget’s Disease Guideline Study Group. J Am Acad Dermatol. 2024 Oct 12:S0190-9622(24)02993-1. doi: 10.1016/j.jaad.2024.07.1531. Epub ahead of print. PMID: 39401611.
Extramammary Paget’s Disease Guideline Study Group: Jake X Wang, Vishnu Harikumar, Malia B Downing, Sumaira Z Aasi, Phyu P Aung, Christopher A Barker, Diana Bolotin, Jeremy S Bordeaux, Todd V Cartee, Sunandana Chandra, Nancy L Cho, Jennifer N Choi, Kee Yang Chung, William A Cliby, Oliver Dorigo, Daniel B Eisen, Yasuhiro Fujisawa, Nicholas Golda, Thorvardur R Halfdanarson, Christos Iavazzo, Shang I Brian Jiang, Esther M John, Jean Kanitakis, Emily L Keimig, Ashraf Khan, Eleni Linos, John Y S Kim, Timothy M Kuzel, Naomi Lawrence, Mario M Leitao Jr, Allan B MacLean, Ian A Maher, Bharat B Mittal, Kishwer S Nehal, David M Ozog, Curtis A Pettaway, Neil Rajan, Jeffrey S Ross, Anthony M Rossi, Sabah Servaes, Michael J Solomon, Valencia D Thomas, Maria Tolia, Bryan B Voelzke, Abigail Waldman, Michael K Wong, Youwen Zhou, Alexandria Brackett, Emily Poon, Areeba Ahmed.
131. Assessing Preoperative (EORTC) QLQ-C30 Score in Elderly Patients with Colorectal Cancer: Results from a Prospective Cohort Study. Samara AA, Diamantis A, Magouliotis D, Tolia M, Tsavalas V, Tzovaras G, Tepetes K. J Clin Med. 2024 Oct 17;13(20):6193. doi: 10.3390/jcm13206193. PMID: 39458143; PMCID: PMC11508690.
132. Comparison between the SGRT and the conventional setup method for patients undergoing VMAT for pelvic malignancies. Sotiropoulou V, Tsironi F, Tolia M, Mazonakis M. Appl Radiat Isot. 2025 Jan 3;217:111659. doi: 10.1016/j.apradiso.2025.111659. Epub ahead of print. PMID: 39778323.
133. Christmas and New Year for Cancer Patients: Ideas for Relief and Entertainment in the Spotlight. Tolia M, Dakanalis A, Mauri D, Kamposioras K, Milaki G, et al. (2025) J Oncol Res Ther 10: 10261. https://doi.org/10.29011/2574-710X.10261.
134. Proton-Based Radiation Therapy for Skull Base Chondrosarcomas in Children and Adolescents: 40-Year Experience From the Massachusetts General Hospital. Myrsini Ioakeim-Ioannidou, Saveli Goldberg, Tobias Urell, Athena Tejada, G. Petur Nielsen, Yin P. Hung, Judith Adams, Barbara Fullerton, Paul Caruso, Manuel Patino, Karen Buch, Sandra Rincon, Osamu Sakai, Maria Tolia, David Ebb, Gregory Cote, William Curry, Drosoula Giantsoudi, Shannon M. MacDonald. International Journal of Radiation Oncology Biology Physics. 2025; 121 (2): 403-413. ISSN 0360-3016. https://doi.org/10.1016/j.ijrobp.2024.09.030. (https://www.sciencedirect.com/science/article/pii/S0360301624034011)
135. Long-term Outcomes Following Proton-based Radiation Therapy for Pediatric Chordomas and Chondrosarcomas of the Mobile Spine and the Sacrum. Ioakeim-Ioannidou M, Niemierko A, Mukhammadov T, Giantsoudi D, Konieczkowski DJ, Kim DW, Tejada A, Tolia M, Nielsen GP, Hung YP, Cote G, Tobert DG, Shin J, DeLaney TF, Chen YL, Giap F, MacDonald SM. Int J Radiat Oncol Biol Phys. 2025 Sep 1;123(1):63-73. doi: 10.1016/j.ijrobp.2025.03.075. Epub 2025 Apr 7. PMID: 40204245.
Non ISI Publications
1. Meta-analysis of the predictive value of KRAS mutations in treatment response using cetuximab in colorectal cancer. Tsoukalas N, Tzovaras A, Tolia Μ, Kostakis ID, Papakostidi A, Pistamaltzian N, Ardavanis A. J BUON. 2012;17(1):73-78.
2. Radiotherapy for Hodgkin’s lymphoma: too hard to die? A.G. Zygogianni, G. Kyrgias, A. Psyrri, I. Kantzou, A. Koumarianou, M. Tolia, P. Tsekeris, P. Tsirigotis, G. Sarris, J. Kouvaris, V. Kouloulias. JBUON. 2012;17(1): 116-123.
3.Radiobiological and quality of life study of conventional and accelerated fractionated radiotherapy in patients with head and neck squamous cell carcinoma: Correlation of efficacy with cell cycle analysis parameters. Tolia M, Karakitsos P, Margari N, Meristoudis C, Kouvaris J, Mystakidou K, Zygogianni A, Gouliamos A, Giotakis I, Maragoudakis P, Psyrri A, Kelekis N, Kouloulias V. Head and Neck Oncology. 2013; 5(4):36
4. Male breast carcinoma: epidemiology, risk factors and current therapeutic approaches. Zygogianni AG, Kyrgias G, Gennatas C, Ilknur A, Armonis V, Tolia M, Papaloukas C, Pistevou Κ, Kouvaris J, Kouloulias V. Asian Pac J Cancer Prev. 2012;13(1):15-19.
5. Three dimensional conformal radiotherapy for hepatocellular carcinoma in patients unfit for resection, ablation or chemotherapy: A retrospective study. V Kouloulias, E Mosa, J Georgakopoulos, K Platoni, E Brountzos, A Zygogianni, C Antypas, P Kosmidis, K Mystakidou, M Tolia, I Beli, A Gouliamos, J Kouvaris, N Kelekis. The Scientific World Journal. 2013:780141.
6. Efficacy and toxicity of radiotherapy for Graves’ ophthalmopathy: the University of Athens experience. Kouloulias V, Kouvaris J, Zygogianni A, Mosa E, Georgakopoulos J, Theodosiadis P, Antypas C, Platoni K, Tolia M, Beli I, Alonistiotis D, Dilvoi M, Patatoukas G, Asimakopoulos C, Efstathopoulos E, Kelekis N. Head Neck Oncol. 2013; 5(2):12.
7. Evaluation of Efficacy and Toxicity in two different Hypofractionated 3D Conformal External Beam Radiotherapy (3D-CRT) schedules, in localised muscle invasive bladder cancer. Kouloulias V, Mosa E, Tolia M, Kantzou I, Koliarakis N, Platoni K, Georgakopoulos J, Siatelis A, Sarris G, Beli I, Chrisofos M, Kelekis N. JBUON 2013;18(4):942-948.
8. Quality Assurance in Health Services: the Paradigm of Radiotherapy. A. Papakostidi, M Tolia, N. Tsoukalas. JBUON. 2014;19(1): 47-52.
9. Hypofractionated radiotherapy schedule with 57.75 Gy in 21 fractions for T1-2N0 prostate carcinoma: Analysis of late toxicity and efficacy. Kouloulias V, Zygogianni A, Tolia M, Platoni K, Kantzou I, Antypas Ch, Chaldeopoulos D, Pantelakos P, Siatelis A, Beli I, Dilvoi M, Georgakopoulos I, Kouvaris J, Kelekis N. J BUON. 2014;19(3):763-9.
10. Radiotherapy combined with daily escitalopram in patients with painful bone metastasis: Clinical evaluation and quality of life measurements. Tolia M, Fotineas A, Nikolaou K, Rizos E, Pantelakos P, Platoni K, Kantzou I, Kelekis N, Kouloulias V. J BUON. 2014;19(3):819-25.
11. Addressing the post-irradiation hypothalamic-pituitary endocrine abnormalities of brain tumors in pediatric patients. L Velentza, M Tolia*, Ch Christakou, M Nikolaou, I Zerdes, N Tsoukalas,J Hajiioannou, K Tsanadis, G Rigas, M Mitsis, K Theodorou, K Pistevou-Gombaki, P Tsekeris, G Kyrgias. JBUON 2017; 22(5): 1240-1245.
12. How can we effectively address the paraneoplastic dermatomyositis: Diagnosis, risk factors and treatment options. Zerdes Ι, Tolia Μ*, Nikolaou Μ, Tsoukalas Ν, Velentza L, Hajiioannou J, Mitsis M, Kyrgias G. JBUON 2017; 22(4): 1073-1080.
13. Is there any potential clinical impact of serum phosphorus and magnesium in patients with lung cancer at first diagnosis? A multi-institutional study. Kouloulias V, Tolia M, Tsoukalas N, Papaloucas C, Pistevou-Gombaki K, Zygogianni A, Mystakidou K, Kouvaris J, Papaloucas M, Psyrri A, Kyrgias G, Gennimata V, Leventakos K, Panayiotides I, Liakouli Z, Kelekis N, Papaloucas A.
Asian Pac J Cancer Prev. 2015;16(1):77-81.
14. Carcinoembryonic antigen and carbohydrate antigen 19-9 serum levels in non-small cell lung cancer. N Tsoukalas, ID Kostakis, C Giaginis, M Tolia, M Galanopoulos, M Kiakou, E Aravantinou-Fatorou, K Tsapakidis, P Baxevanos, I Litos, V Tzouda, A Tzovaras, G Kyrgias, E Tsiambas, S Theocharis. JBUON 2017; 22(6): 1390-1394
15. Stage-II Thymoma and emergency coronary artery bypass. To irradiate or not to irradiate to avoid radiation induced vascular injury? Case report and literature review. I Kouerinis, M Tolia*, F Zagouri, M Nikolaou, N Tsoukalas, G Kyrgias, M-A Dimopoulos, C Vlachopoulos, I Karathanassis, C Zoubouli, I Kokakis, V Kouloulias, K Triantafillou. JBUON 2017; 22(6):1385-1389.
16. The first implementation of IMRT technique for head & neck and prostate cancer patients in public sector in Greece: feasibility, treatment planning and dose delivery verification using the delta(4PT) Pre-Treatment volumetric quality assurance system. Kouloulias V, Antypas C, Liakouli Z, Armpilia C, Zygogianni A, Floros I, Tolia M, Kokakis J, Kouvaris J. J BUON. 2015;20(1):196-205.
17. A Rare Case of Merkel Cell Carcinoma Presented with Lambert Eaton Myasthenic Syndrome without Cutaneous Findings. K Tsapakidis, I Samaras, K Papacharalampous, E Maragkouli, V Papadopoulos, I Litos, Esogka, M Tolia, GK Koukoulis, G Papatsimpas. Canc Therapy & Oncol Int J. 2017;4(2): CTOIJ.MS.ID.555631
18. Health related quality of life of young women with breast cancer. Review of literature. A Yfantis, G Intas, M Tolia, M Nikolaou, N Tsoukalas, M Lymperi, G Kyrgias, G Zografos, M Kontos. JBUON. 2018;23(1):1-6.
19. A five split-field three dimensional conformal technique versus an anterior-posterior on in postoperative radiotherapy for gastric carcinoma: a multicenter comparative study using quality of life measurements as well as clinical and dosimetric parameters.A Zygogianni, A Fotineas, K Platoni, G Patatoukas, M Dilvoi, C Antypas, C Armpilia, N Arkadopoulos, A Psyrri, G Koukourakis, J Kouvaris, Z Liakouli, G Kyrgias, M-A Kalogeridi, M Tolia, N Trogkanis, A Kougioumtzopoulou, E Kypraiou, N Kelekis, V Kouloulias. JBUON. 2018; 23(4): 1020-1028.
20. Clinical value of significance of Hypoxia Inducible Factor-1α, Glucose Transporter-1 and Carbonic Anhydrase IX in rectal cancer after preoperative chemoradiotherapy. D-I. Vitoratou, M. Tolia*, P. Liakos, N. Tsoukalas, C. Giaginis, M. Nicolaou, G. Nikolaou, G. Rigas, K. Psarianos, A. Lioupis, G, Kyrgias. J BUON. 2019;24(2):456-463.
21. Percutaneous-computed-tomography- guided localization of pulmonary nodules with hook wire prior to video-assisted thoracoscopic surgery. S. Manouvelou, E. Mosa, M. Tolia*, N. Tsoukalas, M. Nikolaou, A. Dountsis, E. Andriotis, K. Vasilikos, G. Kyrgias. JBUON 2019; 24(1): 267-272.
22. Evaluation of Quality of Life Outcomes Following Palliative Radiotherapy in Bone Metastases: A Literature Review. C. Koufopoulou, E. Mosa, N. Charalampakis, M. Nikolaou, N. Tsoukalas, I. Nixon, H-H. Saraireh, J. Hajiioannou, D. Kardamakis, G. Kyrgias, M. Tolia. JBUON. 2019. J BUON. 2019;24(5):1747-1760.
23. PD-1 and PD-L1 as immunotherapy targets and biomarkers in non-small cell lung cancer. Tsoukalas N, Kiakou M, Tsapakidis K, Tolia M, Aravantinou-Fatorou E, Baxevanos P, Kyrgias G, Theocharis S. J BUON. 2019; 24(3): 883-888.
24. Gastrointestinal stromal tumors (GISTs) and synchronous intra-abdominal malignancies: case series of a single institution’s experience. Diamantis A, Samara AA, Symeonidis D, Baloyiannis I, Vasdeki D, Tolia M, Volakakis G, Mavrovounis G, Tepetes K. Oncotarget. 2020 Dec 29;11(52):4813-4821. doi: 10.18632/oncotarget.27853. eCollection 2020 Dec 29.
25. Isolated ZIC4 Antibodies and Autoimmune Encephalitis in a Microsatellite-Instability-High Metastatic Uterine Carcinosarcoma during Immune Checkpoint Inhibitor Treatment.N Charalampakis, N Tsoukalas, S Kykalos, M Tolia. Arch Clin Med Case Rep. 2019; 3 (6): 397-401.
26. Ways to Improve Radiation-Induced Sexual Toxicity in Gynecologic Cancer. Chounta E, Skoutari A, Samara A, Antoniades C, Mauri D, Tsoukalas N, Charalampakis N, Tolia M. (2021) J Womens Health, Issues Care 10:8.
27. Inmate cancer patient – Highlighting the importance of a holistic approach to oncological care. M Tolia, EK Symvoulakis, K Kamposioras, D Mauri, A Skoutari, P Volkos, D Schizas, A Spanos, I Kokakis, N Tsoukalas, N Charalampakis, F Cuccia, F Alongi, RA de Mello, KM Antoniou, T Hyphantis, I Nixon, D Matthaios, M Nikolaou, F de Lorenzo, K Apostolidis. JBUON 2021; 26(6): 2688-2703.
28. Dance Movement Psychotherapy in Breast Cancer: “Throwing the Βall to Μount Olympus”. Karaferi S, Papaliagka (Papaliaga) MN, Tolia M, Poultsidi A, Felemegas PD, Bonotis K. Psych. 2022; 4(2):281-291. https://doi.org/10.3390/psych4020025
29. The Potential of Phase Angle as a Nutritional Assessment Tool and Prognostic Factor in Patients with Gastrointestinal Cancers. Mantzorou M, Tolia M, Pavlidou M, Vasios GK, Papandreou D, Papadopoulou SK, et al. Austin J Nutri Food Sci. 2022; 10(1): 1162.
30. A Rare Case of Primary Carcinosarcoma of the Breast. M Kiakou, M Tolia, N Koufopoulos, K Tsapakidis,E Arvanitou, Gkikas K, N Charalambakis, M Nikolaou, D Matthaios, N Tsoukalas. FCO. 2022: 13(1);48–52. DOI: 10.2478/fco-2022-0006.
31. Behind the numbers and the panic of a viral pandemic: fixed restrictive oncology guidance may jeopardize patients’ survival. D Mauri, D Tzachanis, A Valachis, K Kamposioras, M Tolia, M Dambrosio, G Zarkavelis, S Gkoura, I Gazouli, F De Lorenzo, K Apostolidis et al. JBUON 2020; 25(3): 1277-1280.
32. Advanced germ cell tumors and chemotherapy in G6PD deficient patients: Yes to chemotherapy but no to rasburicase and some premedications. Gazouli I, Baltogiannis D, Ntellas P, Smaragdi Vlachou M, Tagkas C, Champilomatis I, Kampletsas Ε, Tolia M, Mauri D. J BUON. 2021 Jul-Aug;26(4):1642-1646. PMID: 34565030.
33. The surgical challenge of oligometastatic pancreatic cancer: A systemic review of the literature. Christodoulidis G, Magouliotis E, Samara AA, Floros T, Zotos PA, Tolia M, Zacharoulis D. J BUON. 2021 Sep-Oct;26(5):1742-1746. PMID: 34761577.
34. A rare case of a primary malignant anorectal melanoma. Văcărașu A, Iosifescu R, Zamfir M, Mardare M, Bondoc I, Călin C, Ali L, Galateanu B, Nikolouzakis TK, Tolia M, Ginghină O. Public Health and Toxicology. 2023;3(1):1. https://doi.org/10.18332/pht/159114.
35. Metachronous Single Pulmonary Metastasis of Prostate Cancer: Report of a Rare Case and Literature Review. Kokkalis A, Samara AA, Papadopoulos V, Tolia M, Tsoukalas N, Tsapakidis K. Cancer Diagn Progn. 2023 Mar 3;3(2):157-162. doi: 10.21873/cdp.10195.
36. The Clinical Significance of MicroRNAs in Colorectal Cancer Signaling Pathways: A Review. Michas A, Michas V, Anagnostou E, Galanopoulos M, Tolia M, Tsoukalas N. Glob Med Genet. 2023 Nov 22;10(4):315-323. doi: 10.1055/s-0043-1777094. PMID: 38025193; PMCID: PMC10665125.
37. Pseudomyxoma Peritonei: A Challenging Clinical Diagnosis. Case Report and Review of the Literature. Tsoukalas N, Tsapakidis K, Tolia M, Kiakou M, Galanopoulos M, Aravantinou-Fatorou E, Kamposioras K. (2024). Cancer diagnosis & prognosis, 4(2), 198-203.
Hellenic (12)
1. Hellenic Society of Radiation Oncology (HSRO)
2. Hellenic College of Radiology
3. Hellenic Society of Radiotherapy Scientists-Employees
4. Hellenic Society of Geriatric Oncology
5. Hellenic Society of Head and Neck Oncology
6. Hellenic Lymphological Society (HEL).2016 -2021
7. Hellenic Society of Cancer Markers and Targeted Therapy
8. Hellenic Society of Head and Neck Oncology
9. Federation of Hellenic Head and Neck Societies
10. Hellenic Lymphological Society (HEL)
11. W40-Hellas, Women in Oncology
12. Member of the Hellenic Alliance for Metastatic Breast Cancer
International (10)
1. European Society of Radiotherapy and Oncology (ESTRO)
2. Associazione Radioterapia e dell’Oncologia Clinica italiana (AIRO)
3. Associazione Italiana di Radiobiologia (AIBRO)
4. European Head and Neck Society (EHNS)
5. Multicentre Italian Trials in Ovarian Cancer (MITO)
6. AllCan Greece/International
7. The International Society for Radiotherapy for Benign Conditions
8. Pancypriot Medical Association
9. European Society of Cardiology – Council on Cardio-Oncology
10. Middle East Society of Therapeutic Radiation Oncology (MESTRO)
